LANGLEY, R. G.; CROWLEY, J.; GOODERHAM, M.; PAPP, K. A.; KORMAN, N. J.; SPELMAN, L.; IGARASHI, A.; OHTSUKI, M.; GUPTA, A. K.; YAMAUCHI, P.; PARNO, J.; MENDELSOHN, A. M.; ROZZO, S. J.; EADS, K. Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s39, 2020. DOI: 10.25251/skin.4.supp.39. Disponível em: Acesso em: 5 jul. 2022.